The route covers a distance of approximately 400 miles.
Oscar said: “My goals for the event are to raise awareness about mental health within the veterinary profession and demonstrate how being in the countryside can boost wellbeing. Along the way, I’m keen to fundraise as much as possible for Vetlife.
“Vetlife has done so much for the veterinary profession with regards to making mental health support more accessible.
"Having that knowledge that they are there personally provides a lot of comfort in what can sometimes be quite a lonely and isolating profession.”
Fellow cyclist and Vetlife trustee Danny Chambers said: “I know how painful it is to cycle up Cheddar Gorge in North Somerset, so I am in awe that Oscar is cycling a 400-mile route around that terrain to visit every vet practice in Somerset in 2 days.
"I’m sure in his brief visits to each practice he’ll get a warm welcome and some sustenance to help him along to his next pit stop!
"Thank you to Oscar for his enthusiasm and support.”
Oscar is inviting others in the veterinary community to join sections of the journey along the way.
For more information on how to get involved with the cycle, visit the Somervet Facebook group: https://www.facebook.com/groups/1930480070643515.
Donate to the fundraiser via the Somervet JustGiving page: https://www.justgiving.com/page/ride-somervet
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.
The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.
The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.
The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.
The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.
The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.
The Committee found all elements of the charges proven.
The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.
These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.
Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.
The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.
In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.
"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.
"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”
The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.
It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.
It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.
Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.
Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.
"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.
“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.
"The respondent had ample opportunities for reflection before resolving to act as he did.
"This places his acts of dishonesty in the most serious category.
“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.
"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”
www.rcvs.org.uk/disciplinary
The British Veterinary Association has warned that political measures to reduce antimicrobial resistance in Europe and the UK are in danger of becoming kneejerk reactions that are not based on sound science.
The warning comes ahead of European Antibiotic Awareness Day on 18th November.
To mark the Awareness Day BVA President Peter Jones delivered a webinar to over 300 veterinary surgeons titled "Resisting antimicrobials - are we acting responsibly?" hosted by The Webinar Vet and available to view at www.thewebinarvet.com/bva-webinars.
Peter said: "Any measures to tackle antimicrobial resistance must be based on sound science. At the moment we are resisting calls from parliamentarians and pressure groups in Europe and the UK to significantly restrict a veterinary surgeon's right to prescribe and dispense medicines according to clinical and professional judgement.
"These calls do not reflect the available science. We know from the USA and Denmark that banning or restricting the use of certain antimicrobials in certain species has not reduced the incidence of resistance to certain organisms in humans. Banning the veterinary use of antimicrobials could have a severe impact on animal health and welfare without achieving the desired impact in humans.
"Scientists also agree that human prescribing is more likely to have an impact on human medicine than veterinary use; but that responsible prescribing is essential in both sectors.
"We fully support measures to encourage responsible veterinary use, particularly of those classes of antimicrobial that are critical for human use such as fluoroquinolones and 3rd and 4th generation cephalosporins. The BVA responsible use poster states that these medicines should be reserved for clinical conditions that respond poorly to other classes of antimicrobials and where antibiotic sensitivity has been carried out, and that they should not be administered systematically to groups or flocks of animals except in very specific situations.
"Vets in the UK should be aware that the new Code of Professional Conduct states that they must be accountable for choices made on antimicrobial use. This is a very positive step forward in promoting the importance of responsible use."
Alan, who is MD of the veterinary business consultancy, Vet Dynamics, will be looking at finances, the team, and scoping out a future strategy. The session will provide practical planning tools, strategic advice, and the opportunity to ask questions.
Bayer points to a number of trends which have emerged during lockdown which it says practices must respond to quickly in the post-lockdown recovery.
The company says retailers have reported that internet traffic increased threefold at the start of lockdown and it remains at double the pre-lockdown levels. Direct retail sales of flea and tick products have also increased.
This suggests that owners are becoming more comfortable with buying preventative healthcare products online.
Bayer says there is a business opportunity here for practices. The subscription box market is expected to hit £1 billion by 20222, and one way practices can capitalise on this trend is by offering home-delivered flea, wormer and tick treatments.
Another business opportunity could lie in research by Banfield Pet Hospital among 1,000 US pet owners in which 20% vowed to take their pets ‘more often’ to the vet post-lockdown for preventative care checkups3.
Caroline Braidwood, Regional Business Manager of Bayer Animal Health said: "We know that many veterinary customers have potentially gone elsewhere during the pandemic and vets will need to work hard to win them back. Our webinar will provide tangible insights to ensure that practices can flourish. Whether you’ve worked with Bayer or not, our team of Veterinary Business Managers are here to help. We’re all in this together, and with some planning, we can ensure the veterinary industry continues to grow.”
To book your webinar place, visit: https://event.webinarjam.com/register/46/rk71qav5
Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said: “Neonatal calf diarrhoea is a leading cause of death in the calf crop in the UK and Ireland.
"We are delighted to therefore offer this webinar discussing up to date information on what we can do to boost neonatal defences in the face of an NCD outbreak.
"Tune in to learn more about the importance of colostral antibodies and how the resecretion of antibodies plays a key role in gut protection.
"We will also discuss what factors can influence the effectiveness of a NCD vaccination programme and what this means for your farmers.”
You'll be able to ask questions during the event and the webinar will also be made available to watch on demand afterwards.
https://www.thewebinarvet.com/pages/forte-healthcare-register
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
Mike Martin, an RCVS Specialist in Veterinary Cardiology, has launched a new reference library of cardiology echo scans on VetSurgeon.org.
The movies show cardiac scans performed on normal dogs, and on cats and dogs with a variety of different conditions, both acquired and congenital.
Mike said: "I hope these movies will be a really helpful reference for colleagues who have an interest in cardiology. They provide so much more information than can be gleaned from a still image in a textbook, now that online video quality has improved so much."
Mike's gallery is an excellent example of the way in which a social networking website like VetSurgeon allows its members to share information and collaborate. Other referral practitioners interested in having their own gallery in which to share videos or images with colleagues in the profession should contact the site editor, Arlo Guthrie for further details.
Click here to visit Mike Martin's Cardiology Gallery
Woodley Equipment Company Ltd has been appointed as the UK and European master veterinary distributor for the Mythic 18 Vet haematology analyser manufactured by Orphee-Medical, Switzerland.
The Mythic 18 Vet is a fully automated, 18 parameter haematology analyser dedicated for veterinary applications. Woodley says it delivers the ultimate technology in haematology, requires little maintenance and benefits from low reagent consumption. It's quick and easy to use with touch screen technology and can produce accurate results in just 60 seconds for over 10 different species using a small sample volume.
For more information, visit: www.woodleyequipment.com, email: sales@woodleyequipment.com or call: +44(0)1204 669033
The RCVS has published a list of 369 veterinary surgeons who missed the 31st May deadline for retention fee payments, were removed from the Register and not restored by 24 June, on its website.
The College says it publishes the list to alert those vets who have not replied to its communications to check their Register status, and to remind veterinary employers to check the registration status of their employees. The registration status of any vet or VN can be checked online at www.rcvs.org.uk/check-the-register.
Information about restoration, and an application form, can be found at www.rcvs.org.uk/registration, or by contacting the RCVS Registration Department: membership@rcvs.org.uk.
For a veterinary surgeon to be restored, a restoration fee needs to be paid, as well as the annual retention fee. The restoration fee is at least £299, and multiplies each successive year a removed member remains off the Register.
A veterinary surgeon's registration acts as a licence to practise and those removed from the Register may not practise unless and until they have been restored.
To enter the competition, veterinary practices need to build a den in the waiting room - with an Adaptil diffuser plugged in nearby - and decorate it to demonstrate the preventative measures clients can carry out at home to help manage their pets’ firework fears.
Then post a picture of the your den/waiting room display on the Ceva Animal Health Facebook page throughout October. Last year's winner is pictured above right.
The top 10 veterinary practice waiting room dens and displays will win a luxury chocolate hamper.
Ceva says it has a comprehensive range of marketing materials for veterinary practices to use in creating their entry, including new waiting room materials.
For further information contact your local Ceva territory manager.
There are 10 candidates standing for the three available elected places on RCVS Council.
The candidates are:
The biographies and election statements for each candidate are available at www.rcvs.org.uk/vetvote23.
Ahead of the start of the election in mid-March, the RCVS is asking veterinary surgeons to email questions for candidates to: vetvote23@rcvs.org.uk in order to better understand them and their views.
You have until Friday 24 February 2023 to submit your question.
The voting period for RCVS Council opens on Monday 13th March and closes at 5pm on Friday 21 April 2023.
Equine charity The Horse Trust has reported an unprecendented number of enquiries from people wanting to rehome their horses and ponies.
In the three weeks since the financial crisis resulted in repossessions, job losses and cash shortages, more than 500 people made inquiries about having their horses rescued or rehomed.
Susan Lewis, The Horse Trust's marketing manager said: "There is a new generation of horses which is being affected in this way. Animals which have been cherished for 20 years and are now approaching retirement age are becoming too expensive for owners to maintain at livery - especially as the winter season is approaching with its inherent requirements for additional feed, housing and veterinary care."
She added: "Most people are saying: 'Help, what can I do? I adore my horse which has lived with me since I was a tiny child - but now I can barely feed myself let alone my horse. He has always come first - but having lost my home and the field in which I keep him, I just don't know where to turn'.
"It isn't a new story - and we have for many years warned horse owners that they face the issues of cost, care and commitment well into the old age of a horse, which can be up to 30 years. Now, however, it seems that we are facing a more widespread crisis."
Like most other horse charities, the Trust's Home of Rest for horses is full to capacity.
"We simply can't take on any other animals," said Susan. "The charity pound is now stretched to breaking point as people's purses dry up - and with rising feed prices and veterinary charges, it now costs more than £17 a day to keep a horse here.
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
The proceedings will begin at 10am with the formal adoption by RCVS Council of the Annual Report and Financial Statements for 2020, which will be published prior to the event.
The College will then answer any written questions that have been submitted about the Annual Report by veterinary surgeons and veterinary nurses.
If you have any questions about the Annual Report, you'll need to submit them to RCVS Events Manager Deborah Rowlanes on d.rowlanes@rcvs.org.uk no later than Friday 2 July 2021.
RCVS President Mandisa Greene will then formally welcome the newly-elected RCVS Council members – Louise Allum, Danny Chambers, Tshidi Gardiner and Colin Whiting – onto Council for their four-year terms, and newly-elected VN Council members Susan Howarth and Donna Lewis for their three-year terms, as well as saying farewell to retiring members of both Councils.
After a short break, the AGM will reconvene at 11am to approve Kate Richards (pictured right) as President for 2021-22, Melissa Donald as Junior Vice-President, Mandisa as Senior Vice-President, and Niall Connell as Treasurer.
There will then be addresses from Matthew Rendle as Chair of Veterinary Nurses Council, and from Mandisa as the outgoing RCVS President for 2020-21, followed by the formal investiture of the new RCVS Officer Team.
There will then be closing remarks from Kate Richards as the newly invested RCVS President.
If you'd like to attend the AGM, you'll need to register here: www.rcvs.org.uk/agm21-registration.
The lectures, which are sponsored by Pinmoore Animal Laboratory Services, aim to dispel many of the myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
Techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques for a wide variety of exotic species will be discussed at length.
Delegates will also get lecture notes, a CPD certificate, goodie bags, refreshments and lunch, not to mention the chance to discuss the day's content with Sonya,
To book your place or for more information, please email us via info@justexotics.co.uk.
The talk, which is sponsored by Supreme Petfoods, will be co-delivered by Craig Tessyman, who works alongside Molly as Exotics Veterinary Nurse Team Leader at Rutland House Veterinary Referrals.
The presentation will focus on the main aspects of emergency care, including best practice for managing these cases in first opinion practice.
Topics will include restoring and maintaining fluid balance, cardio-pulmonary resuscitation (CPR), analgesia options and the importance of appropriate monitoring.
Molly said: “The basic principles of emergency care apply to all species, but with small herbivores, rapid intervention is crucial as their delicate physiology can quickly spiral into crisis when they become unwell.
"In this session, Craig and I will share practical tips that vets and nurses can implement immediately, without requiring specialist equipment, to help manage these challenging cases.”
The sixty minute talk will start at 12.50pm in the Gallery Suite 3-4.
For those unable to attend the live event, a recorded version of the presentation will be available here: https://supremepetfoods.com/vet-zone/cpd-webinars-and-videos/
Virbac Animal Health has produced a Pet Oral Hygiene System point of sale kit for practice reception areas.
The pack includes information for owners on periodontal disease and gingivitis and advice on preventative routine care. It also provides guidance for owners who struggle to brush their pet's teeth correctly, including where to find Virbac CET 'You Tube' footage.
Virbac Oral Care product manager Chris Geddes MRCVS says still more is needed when it comes to oral home care: "Some experts state that four out of every five dogs over the age of three suffers from periodontal disease - despite this many pet owners have no form of oral care programme.
"The idea behind this kit is to highlight to owners the importance of oral hygiene at the time when they are in the most appropriate place to get expert advice!"
Packs are free to any practice spending £50.00 or more on the Virbac oral care range including VeggieDent chews and Vet aquadent drinking solution.
For more information contact your local Virbac territory manager or call Virbac on 01359 243243.
Royal Canin has launched a new Skin Care family of dermatological diets, designed for the nutritional support of skin function in dogs with dermatosis unrelated to food intolerance or allergy.
At the same time, Royal Canin has also launched DermAlliance, a campaign to improve skin care knowledge in general veterinary practice. The 2011/2012 DermAlliance campaign will include educational initiatives such as free CPD webinars, a training roadshow, case study collaborations and competitions to win skin disease reference materials.
Gudi Stuttard BVSc MRCVS, Royal Canin's Veterinary Support Manager, said: "The Skin Care diets (available for adult dog, adult small dog and junior small dog) offer veterinarians a proven1 option for the nutritional management of dogs with common skin problems.
She added: "The large volume of skin cases we see in general practice necessitates a certain level of expertise in small animal dermatology and we believe our new Skin Care range, coupled with the creation of our dedicated DermAlliance educational campaign, will help promote greater clarity in an often confusing clinical area."
According to Royal Canin, Skin Care diets help in the nutritional management of dogs with reactive skin; they contain a patented complex to help maintain the barrier effect of the skin and high levels of essential fatty acids to help support healthy skin reactions. They also contain a synergistic complex of antioxidants to help support natural defences, and nutrients to help maintain a healthy digestive system and contribute to good oral health.
Reference
1 In a multi-centre trial on 47 dogs, the average CADESI (canine atopic dermatitis extent and severity index) score of all dogs improved by a factor of three over three months of being fed Skin Care exclusively. Average CADESI scores increased again after dogs returned to their original diets.
The RCVS reports that the Department for Environment, Food and Rural Affairs (Defra) has now finalised the new microchip regulations for England, which include a provision that dog breeders and other individuals who wish to implant microchips and have no previous approved training, must undergo a compulsory training course.
While veterinary surgeons were exempted from this training, Defra initially envisaged that veterinary nurses would be required to undertake it. In a joint letter, that was followed by negotiations with Defra, the Royal College of Veterinary Surgeons (RCVS), the British Veterinary Association (BVA) and the British Veterinary Nursing Association (BVNA), stressed that registered veterinary nurses are already sufficiently trained to be able to safely implant a microchip, and would be doing so under the direction of a veterinary surgeon.
Defra subsequently has agreed that registered veterinary nurses are already sufficiently qualified to implant microchips, and will therefore be exempt from further training requirements when new legislation comes in for England. Wales and Scotland are currently considering the details of implementation.
The Royal College says it is also aware of new Defra microchipping guidelines for England which make it compulsory to report adverse reactions (including migration from the site of implantation) or the failure of a microchip. Gordon Hockey, RCVS Registrar, said: "There is some concern in the profession about this requirement, but Defra have said that they would not enforce this regulation via the courts, or seek to impose fines. The RCVS is likely to amend its supporting guidance later this year to clarify that veterinary surgeons should make appropriate reports, similar to reports for adverse reactions to veterinary medicines. In each case reports can be made online to the Veterinary Medicines Directorate."
To help veterinary surgeons and veterinary nurses, as well as practices, raise awareness of owners' legal obligation to microchip their dogs, the BVA has posters available for all three regions (England, Scotland and Wales) that can be displayed in waiting rooms and surgeries. The posters are available to download from the BVA website: www.bva.co.uk.
BVA President John Blackwell said: "As a founding member of the Microchipping Alliance, which campaigned for compulsory microchipping together with dog welfare organisations, local authorities and others, BVA is delighted with the progress that has been made and it is very good indeed to be less than a year away from mandatory microchipping across the UK.
"But this is where the work begins for veterinary surgeons and nurses. We need to work hard to make owners aware of the new law throughout this year, with animals microchipped as far in advance of the deadline as possible.
"We also need to ensure that microchipping does the job it is intended to do. This process will be helped very much by not compelling veterinary nurses to undertake additional training when they already undertake minor acts of veterinary surgery that are much more complex procedures than implanting a microchip."
Veterinary teams are now being invited to nominate their workplaces for the awards, detailing the ways in which the team’s wellbeing has been supported.
Entrants must show evidence in their workplace of:
Entires can be submitted for the following categories
The BVA is strongly encouraging people to submit nominations as a team.
Entrants will also be required to submit photos showcasing team culture, demonstrating initiatives to aid staff wellbeing or moments of positivity.
BVA Junior Vice President Anna Judson, who will also be one of the judges for the awards, said: “The culture in a workplace has an impact on every aspect of a business, but most especially when it comes to building a happy, healthy and resilient workforce.
"That’s why it’s so important that staff feel heard, valued and supported.
"BVA’s Wellbeing Awards are an important opportunity for teams to shout about innovative practices that are going the extra mile to support wellbeing.
"After all, good veterinary workplaces are good for people, good for animals in their care and ultimately good for business.”
The awards are open to the entire veterinary profession and there is no requirement to be a BVA member.
Winners will be announced at BVA’s Gala Dinner during the London Vet Show in November.
Nominations close on Monday, 11th September 2023.
www.bva.co.uk/wellbeing-awards
Given that vapocoolant is effective immediately, compared to EMLA cream which is recommended to be applied 60 minutes beforehand, the study suggests that in dogs at least, vapocoolant may be the better option in practice.
For the study, researchers from the Royal Veterinary College assessed 83 dogs and 18 cats requiring intravenous catheterisation for either blood donation collection or as oncology patients.
Patients were randomly assigned to receive either EMLA cream or a swab saturated with vapocoolant spray (Ethycalm / Invicta Animal Health) applied before catheterisation, and their reactions were assessed during initial restraint, limb handling, swab application and skin puncture.
Overall, there was no significant difference between vapocoolant spray and EMLA cream, and neither method appeared better at improving patient tolerance of intravenous catheter placement.
Vapocoolant spray was less effective than EMLA cream in reducing adverse reactions to skin puncture during catheterisation in cats, suggesting that EMLA may be preferable for feline patients.
Dogs that received vapocoolant spray showed a greater adverse response during swab application compared to those receiving EMLA, possibly due to the coldness of the swab.
Success of intravenous catheter placement was identical for both anaesthetics.
Dr Richie Trinder, lead author of the study, said: “The study is the first of its kind comparing vapocoolant spray and EMLA, and suggests in this context that the use of vapocoolant spray provides a similar degree of relief as EMLA, but with the added advantage of being instantaneous, instead of needing to wait the recommended 60 minutes for EMLA.”
The Department for Environment Food and Rural affairs has marked the 10th anniversary of the Pet Travel Scheme with the release of some interesting facts and figures...
The scheme started on 28 February 2000 when owners were first able to travel to and from the UK without placing their pets in quarantine, as long as they fulfilled certain important disease control criteria.
A pug called Frodo Baggins was the first animal to travel with a pet passport and since then, 660,000 pet journeys have been made using pet passports.
60 per cent of the pets that have travelled under the scheme belong to UK owners. Animals from Ireland, France, Germany, Belgium and the Netherlands make up about another 20 per cent.
According to Defra, the scheme was set up in response to growing demand from owners to travel with their pets, and the declining risk of disease allowed these changes to be made. In 2004 the European Union followed the UK's lead and introduced a similar system for all Member States which has also proved very successful.
Defra says the success of the scheme is fully demonstrated by the fact that it has not been associated with a single case of rabies. Animal Welfare Minister Jim Fitzpatrick said: "The Pet Travel Scheme was set up to enable British animal owners to enjoy travelling with their pets when they need to. The success of the scheme shows that responsible pet ownership makes a large contribution to managing disease risks effectively."
As rabies in Europe steadily reduces, and with EU harmonised rules continuing to successfully control rabies, Defra says it is monitoring developments in vaccination and disease management in the EU and round the world to ensure that the UK has the most effective and proportionate controls possible as circumstances continue to change.